Abbvie Inc operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Abbvie Inc with three other
companies in this sector in UNITED STATES :
Bristol-Myers Squibb Company
sales of $42.52 billion
of which 28%
was Prioritized Brands-Revlimid),
of which 26%
was Oncology), and
Merck & Co. , Inc.
of which 90%
was Merck Pharmaceutical).
During the year ended December of 2020, sales at
Abbvie Inc were $45.80 billion.
increase of 37.7%
versus 2019, when the company's sales were $33.27 billion.
This was the fifth consecutive year of sales increases at Abbvie Inc
(and since 2015, sales have increased a total of 100%).